Let’s go deeper as to why we do what we do: albumin in spontaneous bacterial peritonitis (SBP)!
- How much albumin is recommended in SBP? (1:45)
- What antibiotics are used for treatment of SBP? (2:30)
- Why do we give albumin in SBP? (4:15)
- How does albumin compare to crystalloid? (7:15)
- Do we always have to give to albumin? (9:00)
- Third generation cephalosporins are the mainstay treatment in Spontaneous Bacterial Peritonitis (SBP). Further attempts change antibiotic frequency and duration have failed to show improvements in mortality in patients with SBP.
- Hepatorenal syndrome worsens mortality in SBP. Administering albumin in SBP has shown significant absolute risk reductions in renal failure and mortality.
- AASLD guidelines recommends 1.5 g albumin per kg body weight within 6 hours of detection of SBP and 1.0 g/kg on day 3 (Class IIa, Level B).
- Do all patients with SBP need albumin? There is some evidence that administrating albumin particularly benefits SBP patients who also have a total bilirubin >4 mg/dL, BUN >30mg/dl or a serum creatinine >1mg/dl.
- 5% albumin is 12.5 grams of albumin diluted into 250cc bag, whereas 25% albumin is 12.5 grams is mixed into 50cc. It is thought that 1 unit of albumin (12.5g) is four times as effective in expanding plasma volume compared to crystalloid but that data for that is not well cited.
- 1:46 Runyon, Bruce “Management of adult patients with ascites due to cirrhosis: update 2012” AASLD Practice Guidelines 2012. https://www.aasld.org/sites/default/files/guideline_documents/adultascitesenhanced.pdf
- 1:50 Trends in pneumonia mortality rates and hospitalization by organism, United States, 2002-2011 https://wwwnc.cdc.gov/eid/article/22/9/15-0680-f2
- 2:30 Felisart J, Rimola A, Arroyo V, Perez-Ayuso RM, Quintero E, Gines P, Rodes J. “Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections.“Hepatology. 1985 May-Jun;5(3):457-62.
- 2:47 Rimola A, et al. “Two different doses of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective randomized, multicenter study.”Hepatology. 1995 Mar;21(3):674-9.
- Runyon BA, McHutchison JG, Antillon MR, Akriviadis EA, Montano AA. “Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis.”Gastroenterology. 1991 Jun;100(6):1737-42.
- 4:00 The SAFE study Investigators “A comparison of albumin and saline for fluid resuscitation in the intensive care unit.” N Engl J Med 2004; 350:2247-2256
- Roberts I, Blackhall K, Alderson P, Bunn F, Schierhout “Human albumin solution in resuscitation and volume expansion in critically ill patients.” Cochrane library. November 2011.
- 4:15 Sort et al. “Effect of Intravenous albumin of renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.” N Engl J Med 1999; 341:403-409
- 7:08 Mendez CM, McClain CJ, Marsano LS “Albumin therapy in clinical practice” Nutrition in Clinical Practice 2005 20:314
- Horsey PJ “The Cochrane 1998 Albumin Review – not all it was cracked up to be.” European Journal of Anaesthesiology October 2002;19:701-704.
- 9:00 Sigal SH, Stanca CM, Vernandez J, Arroyo V, Navasa M “Restricted use of albumin for spontaneous bacterial peritonitis.”Gut. 2007 Apr;56(4):597-9.